Treatment of CCHF with supportive care, favipiravir, and avatrombopag.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 42615533.
- Also identified by DOI 10.1093/cid/ciag415.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We report a severe Crimean-Congo Hemorrhagic Fever case treated with favipiravir and avatrombopag in a high-level isolation unit. This multimodal approach was associated with rapid platelet recovery, reduced transfusion requirements, and viral clearance. Combining targeted antivirals with thrombopoietin receptor agonists represents a promising strategy for managing severe CCHF coagulopathy.